IDR 2260.0
(-3.42%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2503.17 Billion IDR | 29.42% |
2022 | 1934.16 Billion IDR | 0.5% |
2021 | 1924.45 Billion IDR | 49.9% |
2020 | 1283.79 Billion IDR | 28.12% |
2019 | 1002 Billion IDR | 24.31% |
2018 | 806.03 Billion IDR | 27.6% |
2017 | 631.67 Billion IDR | 9.63% |
2016 | 576.18 Billion IDR | 28.31% |
2015 | 449.07 Billion IDR | 31.88% |
2014 | 340.51 Billion IDR | 53.75% |
2013 | 221.47 Billion IDR | 13.87% |
2012 | 194.5 Billion IDR | 16.13% |
2011 | 167.48 Billion IDR | 12.27% |
2010 | 149.17 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 768.28 Billion IDR | 2.97% |
2024 Q1 | 746.13 Billion IDR | 8.4% |
2023 Q4 | 688.34 Billion IDR | -0.27% |
2023 Q2 | 583.03 Billion IDR | 7.65% |
2023 FY | 2503.17 Billion IDR | 29.42% |
2023 Q3 | 690.17 Billion IDR | 18.38% |
2023 Q1 | 541.62 Billion IDR | 1.42% |
2022 Q2 | 421.4 Billion IDR | -11.98% |
2022 Q4 | 534.01 Billion IDR | 6.81% |
2022 FY | 1934.16 Billion IDR | 0.5% |
2022 Q1 | 478.76 Billion IDR | 26.04% |
2022 Q3 | 499.97 Billion IDR | 18.64% |
2021 Q1 | 500.44 Billion IDR | 6.02% |
2021 FY | 1924.45 Billion IDR | 49.9% |
2021 Q3 | 517.57 Billion IDR | -1.71% |
2021 Q4 | 379.86 Billion IDR | -26.61% |
2021 Q2 | 526.57 Billion IDR | 5.22% |
2020 Q4 | 472.05 Billion IDR | 40.6% |
2020 Q2 | 193.87 Billion IDR | -31.28% |
2020 Q3 | 335.74 Billion IDR | 73.18% |
2020 Q1 | 282.12 Billion IDR | 21.41% |
2020 FY | 1283.79 Billion IDR | 28.12% |
2019 Q2 | 242.81 Billion IDR | -6.3% |
2019 FY | 1002 Billion IDR | 24.31% |
2019 Q3 | 267.68 Billion IDR | 10.24% |
2019 Q4 | 232.36 Billion IDR | -13.19% |
2019 Q1 | 259.14 Billion IDR | 11.6% |
2018 Q3 | 211.13 Billion IDR | 16.25% |
2018 Q2 | 181.61 Billion IDR | 0.3% |
2018 Q1 | 181.07 Billion IDR | 7.04% |
2018 FY | 806.03 Billion IDR | 27.6% |
2018 Q4 | 232.2 Billion IDR | 9.98% |
2017 Q2 | 148.33 Billion IDR | -2.89% |
2017 Q1 | 152.75 Billion IDR | 0.79% |
2017 FY | 631.67 Billion IDR | 9.63% |
2017 Q4 | 169.15 Billion IDR | 4.79% |
2017 Q3 | 161.42 Billion IDR | 8.82% |
2016 Q2 | 142.36 Billion IDR | -0.76% |
2016 FY | 576.18 Billion IDR | 28.31% |
2016 Q4 | 151.55 Billion IDR | 9.17% |
2016 Q3 | 138.82 Billion IDR | -2.49% |
2016 Q1 | 143.44 Billion IDR | 19.27% |
2015 Q3 | 113.25 Billion IDR | 1.4% |
2015 Q2 | 111.68 Billion IDR | 7.53% |
2015 Q1 | 103.86 Billion IDR | 16.71% |
2015 FY | 449.07 Billion IDR | 31.88% |
2015 Q4 | 120.26 Billion IDR | 6.2% |
2014 Q1 | 84.63 Billion IDR | 36.3% |
2014 FY | 340.51 Billion IDR | 53.75% |
2014 Q4 | 88.99 Billion IDR | 17.84% |
2014 Q3 | 75.51 Billion IDR | -17.35% |
2014 Q2 | 91.36 Billion IDR | 7.96% |
2013 Q1 | 51.72 Billion IDR | 1.71% |
2013 Q2 | 53.85 Billion IDR | 4.12% |
2013 Q4 | 62.09 Billion IDR | 15.43% |
2013 Q3 | 53.79 Billion IDR | -0.12% |
2013 FY | 221.47 Billion IDR | 13.87% |
2012 Q2 | 48.06 Billion IDR | 6.83% |
2012 Q1 | 44.99 Billion IDR | 2.48% |
2012 FY | 194.5 Billion IDR | 16.13% |
2012 Q3 | 50.58 Billion IDR | 5.25% |
2012 Q4 | 50.85 Billion IDR | 0.53% |
2011 Q3 | 41.82 Billion IDR | 3.86% |
2011 Q2 | 40.27 Billion IDR | -2.9% |
2011 Q4 | 43.9 Billion IDR | 4.96% |
2011 FY | 167.48 Billion IDR | 12.27% |
2011 Q1 | 41.47 Billion IDR | 0.0% |
2010 FY | 149.17 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Bundamedik Tbk | 1488.19 Billion IDR | -68.202% |
PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -931.468% |
PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 56.723% |
PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | 41.299% |
PT Murni Sadar Tbk | 921.91 Billion IDR | -171.519% |
PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | -36.099% |
PT Royal Prima Tbk | 265.33 Billion IDR | -843.395% |
PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -570.374% |
PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | -63.005% |
PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 77.631% |